Total Payments
$3,849
2020 Payments
$109.51
Companies
28
Transactions
155
Medicare Patients
720
Medicare Billing
$47,957
Payment Breakdown by Category
Food & Beverage$3,818 (99.2%)
Education$30.77 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,818 | 153 | 99.2% |
| Education | $30.77 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $973.88 | 30 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $612.49 | 13 | $0 (2019) |
| Amgen Inc. | $510.93 | 14 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $457.82 | 26 | $0 (2019) |
| GlaxoSmithKline, LLC. | $200.47 | 9 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $173.61 | 11 | $0 (2019) |
| PFIZER INC. | $111.27 | 6 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $107.10 | 5 | $0 (2017) |
| SANOFI PASTEUR INC. | $98.72 | 5 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $93.81 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $109.51 | 3 | Lilly USA, LLC ($109.51) |
| 2019 | $1,470 | 46 | Lilly USA, LLC ($687.62) |
| 2018 | $922.71 | 41 | Boehringer Ingelheim Pharmaceuticals, Inc. ($332.13) |
| 2017 | $1,346 | 65 | Amgen Inc. ($225.62) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/26/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $83.60 | General |
| 02/26/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $18.39 | General |
| 02/26/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $7.52 | General |
| 11/20/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $97.27 | General |
| Category: Diabetes | ||||||
| 11/20/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Diabetes | ||||||
| 11/20/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: Diabetes | ||||||
| 11/09/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| Category: Cardiovascular | ||||||
| 10/29/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 10/21/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Bone Health | ||||||
| 10/16/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Endocrinology | ||||||
| 09/17/2019 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT (Drug), FLUZONE HIGH-DOSE, ADACEL | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: VACCINES | ||||||
| 09/17/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Neuroscience | ||||||
| 09/05/2019 | Lilly USA, LLC | BASAGLAR (Drug), SYNJARDY, TRULICITY | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes | ||||||
| 08/30/2019 | Merck Sharp & Dohme Corporation | GARDASIL9 (Biological) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: VACCINE | ||||||
| 08/29/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Bone Health | ||||||
| 08/19/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Endocrinology | ||||||
| 08/03/2019 | Lilly USA, LLC | GLYXAMBI (Drug), BASAGLAR, SYNJARDY | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 07/31/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $22.15 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 07/17/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Respiratory | ||||||
| 07/15/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.09 | General |
| Category: Cardiovascular | ||||||
| 07/08/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Endocrinology | ||||||
| 07/01/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2019 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $125.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 141 | 170 | $29,238 | $13,968 |
| 2022 | 10 | 223 | 248 | $29,057 | $14,585 |
| 2021 | 9 | 217 | 265 | $26,909 | $12,748 |
| 2020 | 4 | 139 | 176 | $18,588 | $6,655 |
Total Patients
720
Total Services
859
Medicare Billing
$47,957
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $12,320 | $6,731 | 54.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 47 | $8,366 | $3,334 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 14 | $3,352 | $1,441 | 43.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,500 | $1,079 | 71.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $1,430 | $653.41 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $1,500 | $544.53 | 36.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 22 | $770.00 | $184.80 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 44 | 44 | $12,320 | $6,769 | 54.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 35 | $6,230 | $2,347 | 37.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $3,000 | $2,056 | 68.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 32 | 32 | $3,200 | $1,154 | 36.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 16 | $1,760 | $740.97 | 42.1% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 15 | 15 | $900.00 | $724.68 | 80.5% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 19 | 19 | $840.00 | $724.47 | 86.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 16 | 23 | $805.00 | $68.19 | 8.5% |
| 91313 | Coronavirus vaccine 14 | Office | 2022 | 19 | 19 | $0.19 | $0.19 | 100.0% |
| 91306 | Sarscov2 vac 50mcg/0.25ml im | Office | 2022 | 15 | 15 | $1.50 | $0.15 | 10.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 63 | $11,214 | $5,130 | 45.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 17 | 17 | $4,760 | $2,659 | 55.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 30 | 30 | $3,000 | $1,958 | 65.3% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 26 | 26 | $1,300 | $1,277 | 98.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 13 | $1,430 | $705.29 | 49.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 29 | 29 | $2,835 | $605.63 | 21.4% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 11 | 11 | $550.00 | $257.89 | 46.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 34 | 52 | $1,820 | $156.00 | 8.6% |
About Dr. Mei-Lai Lucas, MD
Dr. Mei-Lai Lucas, MD is a Internal Medicine healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104806058.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mei-Lai Lucas, MD has received a total of $3,849 in payments from pharmaceutical and medical device companies, with $109.51 received in 2020. These payments were reported across 155 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,818).
As a Medicare-enrolled provider, Lucas has provided services to 720 Medicare beneficiaries, totaling 859 services with total Medicare billing of $47,957. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location San Francisco, CA
- Active Since 01/18/2006
- Last Updated 01/13/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104806058
Products in Payments
- JARDIANCE (Drug) $666.30
- TRULICITY (Drug) $436.79
- Prolia (Biological) $312.22
- FARXIGA (Drug) $262.83
- EVENITY (Biological) $168.85
- JANUVIA (Drug) $137.00
- ADVAIR (Drug) $131.32
- TRADJENTA (Drug) $129.68
- ELIQUIS (Drug) $93.81
- Trintellix (Drug) $91.87
- SYMBICORT (Drug) $88.46
- XIFAXAN (Drug) $80.89
- XIFAXANIBSD (Drug) $55.29
- CHANTIX (Drug) $54.66
- Myrbetriq (Drug) $54.44
- Tymlos (Biological) $52.74
- FLUZONE HIGH-DOSE (Drug) $52.14
- FLUZONE QUADRIVALENT (Drug) $46.58
- BEVESPI AEROSPHERE (Drug) $45.86
- PREVNAR - 13 (Biological) $36.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Francisco
Dr. Fred Cohen, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
John Teerlink, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Kenneth Binmoeller, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Hope Rugo, Md, MD
Internal Medicine — Payments: $881,117
Internal Medicine $881,117
Dr. Steven Harris, M.d, M.D
Internal Medicine — Payments: $806,637
Internal Medicine $806,637
Dr. Kenneth Colley, Md, MD
Internal Medicine — Payments: $732,736
Internal Medicine $732,736